Page last updated: 2024-08-25

oxazolidin-2-one and Extensively Drug-Resistant Tuberculosis

oxazolidin-2-one has been researched along with Extensively Drug-Resistant Tuberculosis in 46 studies

Research

Studies (46)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (17.39)29.6817
2010's37 (80.43)24.3611
2020's1 (2.17)2.80

Authors

AuthorsStudies
Deng, G; Fu, L; Wang, Y; Yang, M; Zhan, S; Zhang, P1
Ahmed, I; Hasan, R; Inayat, R; Jabeen, K1
Centis, R; D'Ambrosio, L; Migliori, GB; Sotgiu, G; Spanevello, A1
Chuchottaworn, C; Roongruangpitayakul, C1
Brito, M; Correia, P; Rodrigues, M; Villar, M1
Balasubramanian, V; Hoffner, S; Perskvist, N; Rodrigues, C; Sambandamurthy, VK; Werngren, J; Wijkander, M1
Andersson, J; Axelsson-Robertson, R; Keshavjee, S; Lutckii, A; Maeurer, M; Master, I; Parida, SK; Rao, MV; Singh, N; Zumla, A1
Gao, M; Huang, H; Pang, Y; Wang, Y; Yu, X; Zhang, L; Zhao, Y1
Chaiprasert, A; Charoensook, S; Leechawengwongs, M; Makhao, N; Prammananan, T; Sirirudeeporn, P; Srimuang, S; Theankeaw, O; Tingtoy, N; Tomnongdee, N1
Chang, KC; Heyckendorf, J; Lange, C; Olaru, ID; von Groote-Bidlingmaier, F; Yew, WW1
Barry, CE; Chen, RY; Cho, SN; Coleman, MT; Dartois, V; Dodd, LE; Flynn, JL; Janssen, C; Kim, Y; Klein, E; Lee, M; Lin, PL; Maiello, P; Marriner, G; Scanga, C; Via, LE; Wang, J1
Bauer, TT; Bettermann, G; Bös, L; Mauch, H; Otto-Knapp, R; Rüssmann, H; Schönfeld, N; Weiss, T1
Castiglia, P; Centis, R; D'Ambrosio, L; Migliori, GB; Sotgiu, G1
Barry, CE; Cho, SN; Jeong, I; Kim, Y; Lee, M; Song, T1
Alsleben, N; Donald, PR; Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS; Willemse, M1
Benson, CA; Maartens, G1
Berry, C; du Cros, P; Phillips, PP; Seddon, JA; Yates, TA1
Condos, R; Hadgiangelis, N; Harkin, T; Jacquette, G; Leibert, E; Rom, WN1
Cho, SN; Koh, WJ; Kwon, OJ; Nam, HS; Shim, TS1
Centis, R; Eker, B; Hoffmann, H; Kirsten, D; Lange, C; Migliori, GB; Muetterlein, R; Ortmann, J; Ruesch-Gerdes, S; Schaberg, T; Sotgiu, G1
Aggarwal, D; Janmeja, AK; Mohapatra, PR1
Donald, PR; Schaaf, HS; Willemse, M1
Centis, R; Eker, B; Guenther, G; Lange, C; Matteelli, A; Migliori, GB; Richardson, MD; Sotgiu, G; Spanevello, A1
Chang, KC; Chau, CH; Yew, WW1
Koh, WJ; Shim, TS1
Alffenaar, JW; Filguera, P; Harmelink, IM; Kosterink, JG; Molenaar, E; Uges, DR; van Altena, R; van der Werf, TS; van Soolingen, D; Wessels, AM1
Dauby, N; Mouchet, F; Muylle, I; Payen, MC; Sergysels, R1
Brito, MJ; Ferreira, G; Gouveia, C; Kjöllerström, P; Varandas, L1
Freeman, JT; Goh, TL; Jones, KL; Towns, CR; Wong, CS1
Barbedo, J; Centis, R; D'Ambrosio, L; Diogo, N; Fernandes, L; Lange, C; Migliori, GB; Raymundo, E; Sotgiu, G; Villar, M1
Bali, RK; Behera, D; Caminero, JA; Gupta, S; Jaiswal, A; Singla, N; Singla, R1
Gu, J; Hao, XH; Liu, YD; Sun, H; Tangg, SJ; Xiao, HP; Yao, L; Zhang, Q; Zheng, LH1
Abbate, E; Ambroggi, M; Cufré, M; García, A; Gonzalez Montaner, P; Natiello, M; Ritacco, V; van Soolingen, D; Vescovo, M1
Campbell, S; Jakubiec, W; Ladutko, L; Miller, PF; Mitton-Fry, M; Paige, D; Silvia, A; Wallis, RS1
Cox, H; Ford, N1
Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Sotgiu, G1
Barry, CE; Cai, Y; Carroll, MW; Choi, H; Goldfeder, LC; Hwang, S; Jeon, HS; Jin, B; Lebron, J; Lee, M; Min, S; Park, H; Park, Y; Song, T; Via, LE1
Alffenaar, JW; Anger, HA; Caminero, JA; Castiglia, P; Centis, R; D'Ambrosio, L; De Lorenzo, S; Ferrara, G; Koh, WJ; Migliori, GB; Schecter, GF; Shim, TS; Singla, R; Skrahina, A; Sotgiu, G; Spanevello, A; Udwadia, ZF; Villar, M; Zampogna, E; Zellweger, JP; Zumla, A1
Alffenaar, JW; Bolhuis, MS; Pranger, AD1
Dong, M; He, J; Jiang, Y; Lei, H; Meng, X; Tong, A; Wang, D; Yang, C; Zhu, L1
Alffenaar, JW; Bolhuis, MS; Centis, R; D'Ambrosio, L; De Lorenzo, S; Migliori, GB; Piana, A; Sotgiu, G; Spanevello, A; Tiberi, S; van Altena, R; Viggiani, P1
Hallbauer, UM; Hesseling, AC; Rose, PC; Schaaf, HS; Seddon, JA1
Barry, CE; Carroll, MW; Chen, RY; Cho, SN; Choi, H; Dartois, V; Follmann, D; Goldfeder, LC; Jeon, HS; Jeong, I; Jin, B; Joh, JS; Kang, E; Kim, CT; Kim, H; Kwak, H; Lee, D; Lee, J; Lee, JK; Lee, M; Min, S; Olivier, KN; Park, H; Park, SK; Shaw, PA; Song, SD; Song, T; Via, LE1
Jaramillo, E; Raviglione, M; Weyer, K1
Agarwal, R; Behera, D; Dhooria, S1
Cattaneo, D; Cordier, L; Orlando, G1

Reviews

4 review(s) available for oxazolidin-2-one and Extensively Drug-Resistant Tuberculosis

ArticleYear
Totally drug-resistant tuberculosis and adjunct therapies.
    Journal of internal medicine, 2015, Volume: 277, Issue:4

    Topics: Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Global Health; Host-Pathogen Interactions; Humans; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones

2015
Novel drugs against tuberculosis: a clinician's perspective.
    The European respiratory journal, 2015, Volume: 45, Issue:4

    Topics: Adamantane; Antitubercular Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diarylquinolines; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Male; Nitroimidazoles; Oxazoles; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2015
Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:4

    Topics: Acetamides; Antitubercular Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2012
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.
    The European respiratory journal, 2012, Volume: 40, Issue:6

    Topics: Acetamides; Adolescent; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Patient Safety; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2012

Trials

4 trial(s) available for oxazolidin-2-one and Extensively Drug-Resistant Tuberculosis

ArticleYear
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
    Clinical pharmacokinetics, 2010, Volume: 49, Issue:8

    Topics: Acetamides; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2010
Linezolid: an effective, safe and cheap drug for patients failing multidrug-resistant tuberculosis treatment in India.
    The European respiratory journal, 2012, Volume: 39, Issue:4

    Topics: Acetamides; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Drug Costs; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; India; Linezolid; Male; Middle Aged; Oxazolidinones; Prospective Studies; Treatment Outcome; Young Adult

2012
Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Volume: 54, Issue:11

    Topics: Acetamides; Adult; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Male; Oxazolidinones; Rhabdomyolysis

2012
Linezolid for treatment of chronic extensively drug-resistant tuberculosis.
    The New England journal of medicine, 2012, Oct-18, Volume: 367, Issue:16

    Topics: Acetamides; Adult; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kaplan-Meier Estimate; Linezolid; Male; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Sputum; Young Adult

2012

Other Studies

38 other study(ies) available for oxazolidin-2-one and Extensively Drug-Resistant Tuberculosis

ArticleYear
Prospects of contezolid (MRX-I) against multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis.
    Drug discoveries & therapeutics, 2022, May-17, Volume: 16, Issue:2

    Topics: Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Pyridones; Tuberculosis, Multidrug-Resistant

2022
Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Acetamides; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Pakistan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2013
Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence.
    The European respiratory journal, 2013, Volume: 42, Issue:1

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2013
Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2013, Volume: 96, Issue:10

    Topics: Acetamides; Adult; Anti-Infective Agents; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Off-Label Use; Oxazolidinones; Retrospective Studies; Thailand; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2013
Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in adolescent patients.
    The Pediatric infectious disease journal, 2014, Volume: 33, Issue:6

    Topics: Acetamides; Adolescent; Antitubercular Agents; Child; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2014
In vitro activity of AZD5847 against geographically diverse clinical isolates of Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7

    Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Pulmonary

2014
Linezolid in the treatment of extensively drug-resistant tuberculosis.
    Infection, 2014, Volume: 42, Issue:4

    Topics: Acetamides; Adolescent; Adult; Aged; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Treatment Outcome; Young Adult

2014
Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:8

    Topics: Acetamides; Aminoglycosides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Thailand; Tuberculosis, Multidrug-Resistant

2014
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.
    Science translational medicine, 2014, Dec-03, Volume: 6, Issue:265

    Topics: Acetamides; Algorithms; Animals; Anti-Bacterial Agents; Extensively Drug-Resistant Tuberculosis; Fluorodeoxyglucose F18; Humans; Linezolid; Lymph Nodes; Macaca; Multimodal Imaging; Oxazolidinones; Positron-Emission Tomography; Stem Cells; Tomography, X-Ray Computed; Treatment Outcome

2014
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
    The European respiratory journal, 2015, Volume: 45, Issue:1

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2015
Low minimal inhibitory concentrations of linezolid against multidrug-resistant tuberculosis strains.
    The European respiratory journal, 2015, Volume: 45, Issue:1

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2015
Linezolid for XDR-TB--Final Study Outcomes.
    The New England journal of medicine, 2015, Jul-16, Volume: 373, Issue:3

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Protein Synthesis Inhibitors; Sputum; Treatment Outcome

2015
Successful Treatment of a Child With Extensively Drug-Resistant Tuberculous Meningitis.
    Journal of the Pediatric Infectious Diseases Society, 2015, Volume: 4, Issue:3

    Topics: Anti-Inflammatory Agents; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Child, Preschool; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Hypothyroidism; Isoxazoles; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Prednisolone; Treatment Outcome; Tuberculosis, Meningeal

2015
Linezolid for Treating Tuberculosis: A Delicate Balancing Act.
    EBioMedicine, 2015, Volume: 2, Issue:11

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Mycobacterium tuberculosis; Oxazolidinones; Treatment Outcome; Tuberculosis; Tuberculosis, Multidrug-Resistant

2015
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.
    The European respiratory journal, 2016, Volume: 47, Issue:5

    Topics: Antitubercular Agents; China; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2016
Case series report of a linezolid-containing regimen for extensively drug-resistant tuberculosis.
    Chest, 2008, Volume: 134, Issue:1

    Topics: Acetamides; Adult; Anti-Infective Agents; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2008
Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    International journal of antimicrobial agents, 2009, Volume: 33, Issue:1

    Topics: Acetamides; Adult; Anti-Infective Agents; Culture Media; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Korea; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult

2009
Multidrug- and extensively drug-resistant tuberculosis, Germany.
    Emerging infectious diseases, 2008, Volume: 14, Issue:11

    Topics: Acetamides; Adult; Antitubercular Agents; Cohort Studies; Drug Resistance, Multiple, Bacterial; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Female; Germany; Humans; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; Risk Factors; Sentinel Surveillance; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2008
Treatment of extensively drug-resistant tuberculosis.
    Lancet (London, England), 2009, Jan-03, Volume: 373, Issue:9657

    Topics: Acetamides; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Dose-Response Relationship, Drug; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Linezolid; Moxifloxacin; Oxazolidinones; Quinolines

2009
Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
    The Pediatric infectious disease journal, 2009, Volume: 28, Issue:8

    Topics: Acetamides; Antitubercular Agents; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Infant; Linezolid; Oxazolidinones; Tuberculosis, Pulmonary

2009
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2009
Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2009
Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    The Journal of antimicrobial chemotherapy, 2009, Volume: 64, Issue:5

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2009
Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
    The Pediatric infectious disease journal, 2011, Volume: 30, Issue:9

    Topics: Acetamides; Adolescent; Antitubercular Agents; Clavulanic Acid; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Meropenem; Oxazolidinones; Thienamycins; Treatment Outcome

2011
Linezolid in the treatment of multidrug-resistant/extensively drug-resistant tuberculosis in paediatric patients: experience of a paediatric infectious diseases unit.
    Scandinavian journal of infectious diseases, 2011, Volume: 43, Issue:6-7

    Topics: Acetamides; Adolescent; Antitubercular Agents; Child; Child, Preschool; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Oxazolidinones; Treatment Outcome

2011
Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country.
    The Medical journal of Australia, 2011, Jun-06, Volume: 194, Issue:11

    Topics: Acetamides; Adult; Aminosalicylic Acid; Antitubercular Agents; Aza Compounds; Cycloserine; Emigrants and Immigrants; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Imipenem; Linezolid; Lymph Nodes; Male; Moxifloxacin; Myanmar; New Zealand; Oxazolidinones; Quinolines; Radiography

2011
Linezolid safety, tolerability and efficacy to treat multidrug- and extensively drug-resistant tuberculosis.
    The European respiratory journal, 2011, Volume: 38, Issue:3

    Topics: Acetamides; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug-Related Side Effects and Adverse Reactions; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Infectious Disease Medicine; Isoniazid; Kanamycin; Linezolid; Male; Middle Aged; Oxazolidinones; Rifampin

2011
Efficacy and safety of linezolid in the treatment of extensively drug-resistant tuberculosis.
    Japanese journal of infectious diseases, 2011, Volume: 64, Issue:6

    Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Drug Monitoring; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Oxazolidinones; Radiography, Thoracic; Sputum; Tomography, X-Ray Computed; Treatment Outcome

2011
Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:2

    Topics: Acetamides; Adult; Antitubercular Agents; Argentina; Aza Compounds; Compassionate Use Trials; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Linezolid; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Oxazolidinones; Quinolines; Retrospective Studies; Thioridazine; Treatment Outcome; Tuberculosis, Pulmonary

2012
Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
    PloS one, 2012, Volume: 7, Issue:1

    Topics: Adamantane; Antitubercular Agents; Diarylquinolines; Drug Monitoring; Drug Therapy, Combination; Ethylenediamines; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazolidinones; Pyrazinamide; Quinolines; Reproducibility of Results; Time Factors

2012
On linezolid efficacy and tolerability.
    The European respiratory journal, 2012, Volume: 39, Issue:3

    Topics: Acetamides; Adult; Antitubercular Agents; Cohort Studies; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Treatment Outcome

2012
Linezolid: safety and efficacy monitoring.
    The European respiratory journal, 2012, Volume: 39, Issue:5

    Topics: Acetamides; Drug Costs; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones

2012
In vitro activity of linezolid against clinical isolates of Mycobacterium tuberculosis, including multidrug-resistant and extensively drug-resistant strains from Beijing, China.
    Japanese journal of infectious diseases, 2012, Volume: 65, Issue:3

    Topics: Acetamides; Antitubercular Agents; China; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxazolidinones; Tuberculosis, Multidrug-Resistant

2012
Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.
    The European respiratory journal, 2013, Volume: 41, Issue:6

    Topics: Acetamides; Adult; Antitubercular Agents; Case-Control Studies; Clavulanic Acid; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Linezolid; Male; Meropenem; Middle Aged; Oxazolidinones; Thienamycins; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2013
Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2012, Volume: 16, Issue:12

    Topics: Acetamides; Adolescent; Age Factors; Anti-HIV Agents; Antitubercular Agents; Child; Child, Preschool; Coinfection; Cost Savings; Drug Costs; Drug Interactions; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Infant; Linezolid; Male; Mycobacterium tuberculosis; Oxazolidinones; Retrospective Studies; South Africa; Sputum; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary

2012
Linezolid for extensively drug-resistant tuberculosis.
    The New England journal of medicine, 2013, 01-17, Volume: 368, Issue:3

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones

2013
Linezolid for extensively drug-resistant tuberculosis.
    The New England journal of medicine, 2013, 01-17, Volume: 368, Issue:3

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones

2013
Linezolid for extensively drug-resistant tuberculosis.
    The New England journal of medicine, 2013, 01-17, Volume: 368, Issue:3

    Topics: Acetamides; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Female; Humans; Male; Oxazolidinones

2013